Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on December 19, 2020.
January 04, 2021 at 09:30 pm IST
Share
From December 18, 2020 to December 31, 2020, the company has repurchased 537,500 shares, representing 0.66% for CNY 9.83 million. With this, the company has completed the repurchase of 537,500 shares, representing 0.66% for CNY 9.83 million under the buyback announced on December 19, 2020.
Edan Instruments, Inc. is a China-based company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. The Company provides maternity product series, including doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors and maternity integrated diagnostic monitoring systems; electrocardiograph series, including digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, electrocardiographic workstations, single-channel electrocardiographs and multi-channel electrocardiographs; monitoring product series, including portable multi-variable monitors, central monitoring systems and oximeters, as well as ultrasonic image product series, including digital ultrasonic diagnostic systems and others. The Company is also involved in the spare parts sale and in vitro diagnostics products business.
EDAN INSTRUMENTS, INC. 
